Gilead Pays 50% Premium for Myogen
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 77 (Table of Contents)
Published: 6 Nov-2006
DOI: 10.3833/pdr.v2006.i77.439 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Gilead entered into acquisition agreement to acquire Myogen, thus strengthening its product portfolio in small molecule therapeutics for treating cardiovascular diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS